mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |